In Lynch syndrome with a hMLH1 or hMSH2 mutation, the frequencies of colorectal and endometrial cancers are 68 and 62%, respectively, and the lifetime risk of developing endometrial cancer is higher than that for colorectal cancer in women [26]. This evidence concerns the gene MSH2 and Lynch syndrome.